当前位置: X-MOL 学术Nat. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis.
Nature Medicine ( IF 58.7 ) Pub Date : 2018-11-12 , DOI: 10.1038/s41591-018-0238-9
Yinghong Wang 1 , Diana H Wiesnoski 2 , Beth A Helmink 3 , Vancheswaran Gopalakrishnan 3 , Kati Choi 4 , Hebert L DuPont 5, 6 , Zhi-Dong Jiang 5 , Hamzah Abu-Sbeih 1 , Christopher A Sanchez 2 , Chia-Chi Chang 2 , Edwin R Parra 7 , Alejandro Francisco-Cruz 7 , Gottumukkala S Raju 1 , John R Stroehlein 1 , Matthew T Campbell 8 , Jianjun Gao 8 , Sumit K Subudhi 8 , Dipen M Maru 9 , Jorge M Blando 10 , Alexander J Lazar 2, 9 , James P Allison 10 , Padmanee Sharma 8, 10 , Michael T Tetzlaff 7, 9 , Jennifer A Wargo 2, 3 , Robert R Jenq 2, 11
Affiliation  

We report the first case series of immune checkpoint inhibitors (ICI)-associated colitis successfully treated with fecal microbiota transplantation, with reconstitution of the gut microbiome and a relative increase in the proportion of regulatory T-cells within the colonic mucosa. These preliminary data provide evidence that modulation of the gut microbiome may abrogate ICI-associated colitis.

中文翻译:

粪便菌群移植治疗难治性免疫检查点抑制剂相关性结肠炎。

我们报告的第一例系列的免疫检查点抑制剂(ICI)相关的结肠炎已成功治疗与粪便微生物群移植,肠道微生物组的重建和结肠黏膜内调节性T细胞的比例相对增加。这些初步数据提供了证据,即肠道微生物组的调节可能会消除ICI相关的结肠炎。
更新日期:2018-11-13
down
wechat
bug